<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/93767">
      <dc:title>Potential clinical applications of extracellular vesicles in pancreatic cancer: exploring untapped opportunities from biomarkers to novel therapeutic approaches</dc:title>
      <dc:creator>Sánchez Manas, José Manuel</dc:creator>
      <dc:creator>Perez de Gracia, Natalia</dc:creator>
      <dc:creator>Perales Romero, Sonia</dc:creator>
      <dc:creator>Martínez Galán, Joaquina</dc:creator>
      <dc:creator>Torres Perales, Carolina</dc:creator>
      <dc:creator>Real, Pedro J.</dc:creator>
      <dc:subject>Extracellular vesicles</dc:subject>
      <dc:subject>pancreatic cancer</dc:subject>
      <dc:subject>liquid biopsy</dc:subject>
      <dc:description>Pancreatic cancer is a highly lethal and metastatic malignancy, mainly because it often remains undetected until&#xd;
advanced stages due to the limitations of current diagnostic methods, rendering currently available therapies&#xd;
ineffective. Therefore, it is imperative to identify useful biomarkers for early diagnosis and new therapeutic targets&#xd;
for pancreatic cancer. Recently, extracellular vesicles have emerged as promising biomarkers for the diagnosis and&#xd;
prognosis of pancreatic cancer. Given their presence in various bodily fluids, extracellular vesicles offer a noninvasive&#xd;
approach through liquid biopsy to detect and monitor cancer progression. In this review, we&#xd;
comprehensively examine the multifaceted roles of extracellular vesicles in the progression of cancer, while also exploring their potential as diagnostic, prognostic, and therapeutic biomarkers in the context of pancreatic cancer.</dc:description>
      <dc:date>2024-09-02T10:49:26Z</dc:date>
      <dc:date>2024-09-02T10:49:26Z</dc:date>
      <dc:date>2024-05-09</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Sanchez Manas, J.M. et. al. 2024;5:180-200. [https://dx.doi.org/10.20517/evcna.2023.68]</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/93767</dc:identifier>
      <dc:identifier>10.20517/evcna.2023.68</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Atribución 4.0 Internacional</dc:rights>
      <dc:publisher>OAE Publishing Inc</dc:publisher>
   </ow:Publication>
</rdf:RDF>